US 11,654,250 B2
Resorbable, drug-eluting submucosal turbinate implant device and method
Jennifer G. Medina, Jacksonville, FL (US); Drew P. Amery, Jacksonville, FL (US); Dana A. Oliver, Jacksonville, FL (US); and Jie Wen, St. Johns, FL (US)
Assigned to Medtronic Xomed, Inc., Jacksonville, FL (US)
Filed by Medtronic Xomed, Inc., Jacksonville, FL (US)
Filed on Mar. 2, 2020, as Appl. No. 16/806,493.
Application 16/806,493 is a continuation of application No. 14/836,594, filed on Aug. 26, 2015, granted, now 10,596,330.
Prior Publication US 2020/0197627 A1, Jun. 25, 2020
This patent is subject to a terminal disclaimer.
Int. Cl. A61M 5/32 (2006.01); A61K 9/00 (2006.01); A61L 31/16 (2006.01); A61B 17/34 (2006.01); A61B 17/24 (2006.01)
CPC A61M 5/3287 (2013.01) [A61B 17/24 (2013.01); A61B 17/3468 (2013.01); A61K 9/0024 (2013.01); A61L 31/16 (2013.01); A61M 5/3286 (2013.01); A61M 2205/04 (2013.01); A61M 2210/0681 (2013.01)] 24 Claims
OG exemplary drawing
 
1. A method for sinus treatment, comprising:
grasping a proximal grip portion of a surgical device outside of a patient;
manipulating the proximal grip portion to pierce mucosal turbinate tissue of the patient with a distal hollow sharp needle portion of the surgical device and submucosally insert the distal hollow sharp needle portion into the mucosal turbinate tissue; and
activating an actuator disposed within the surgical device to deliver one or more biodegradable, drug-eluting solid implants from the distal hollow sharp needle portion into the mucosal turbinate tissue and submucosally bury at least one implant withdrawal discouraging, mucosal tissue-engaging surface feature along a length of each of the one or more implants within the mucosal turbinate tissue.